Welcome to NHLBI-PEN Project
—
filed under:
Executive Committee Meeting
Integrated Nanosystem for Diagnosis and Therapy - Program of Excellence in Nanotechnology
The central mission of this project (Project Number: HL080729) is to develop a group of well-characterized and versatile nanoscale agents that can be assembled, labeled, targeted, filled, and activated as needed for the diagnosis and treatment of various diseases of relevance to the National Heart Lung and Blood Institute (NHLBI).
The overall experimental strategy is focus on biological models of acute pulmonary and systemic vascular injury (in vitro and in vivo) to demonstrate the effectiveness of these agents. Acute vascular injury and inflammation have been chosen as general targets since they affect tissues broadly, including those of the lung and cardiovascular system.
For more information about the NHLBI-PEN Project please contact:
The overall experimental strategy is focus on biological models of acute pulmonary and systemic vascular injury (in vitro and in vivo) to demonstrate the effectiveness of these agents. Acute vascular injury and inflammation have been chosen as general targets since they affect tissues broadly, including those of the lung and cardiovascular system.
For more information about the NHLBI-PEN Project please contact:
|
Karen L. Wooley Department of Chemistry Washington University in St. Louis One Brookings Drive, CB 1134 St. Louis, MO 63130-4899 phone: (314) 935-7136 fax: (314) 935-9844 |
SUIP 2008- A Summer Intership Program
PEN Brochure
Intra-PEN Meeting, July 11-12, 2008
Executive Committee Meeting, September 5, 2008
